Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical enterprise specializing in the production of narcotic drugs and active pharmaceutical ingredients (APIs). Founded in 1958 and headquartered in Xining, it is one of the few companies officially designated by the Chinese government to manufacture controlled substances. The company's extensive portfolio includes essential medicines such as morphine, codeine, and methadone, serving critical needs in pain management and addiction treatment. Since 2003, it has operated as a key subsidiary of Fosun Pharma, benefiting from integrated R&D and global distribution networks. Qinghai Pharmaceutical maintains rigorous GMP standards across its manufacturing facilities to ensure the safety and efficacy of its specialized product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QingHai Pharm.